Rocket Doctor AI (AIDR) investor relations material

Market need

• U.S. primary-care access gaps exceed 100M people; 6.5M+ Canadians lack a family doctor, routine family-MD waits reach 3–6 weeks in smaller communities, and admin consumes 40% of physician time.

• The model combines AI technology, virtual-care delivery, payer access and patient demand in provider-centered platforms.

Traction and financials

• More than 800,000 patient visits completed, 350+ physicians signed to the platform and 120,000+ clinical hours; potential in-network access covers ~24M lives across California, New York and Maryland.

• Q2 2026 revenue was C$734K, up 43% YoY, with 65% gross margin; Canadian patient visits grew 23% YoY in Q2.

• U.S. patient visits rose from 86 in Q4 2025 to 3,911 in Q2 2026; Q3 2026 was estimated at 5,438 based on current monthly averages, with July and August at 3,625 visits.

• Q2 2026 ARR was ~C$2.9M, comprising ~C$2.22M platform usage, ~C$250K partnership revenue and ~C$465K software licensing and service fees; ARR is non-GAAP and stated in USD by definition.

Platform and revenue model

• Global Library of Medicine (GLM), developed since 2016 with 25,000+ clinician-input hours, has 10,000+ expert reviews and supports diagnosis across 1,000+ diseases and 17,000+ symptoms.

• AI tools span pre-visit intake and matching, diagnostic support during visits, and follow-ups; offerings include AI scribe, smart triage, EMR integration and billing/revenue reconciliation.

• Revenue sources include appointment fees, physician platform fees, pharmacy and allied-health partnerships, and GLM licensing; current agreements support minimum commitments through 2027.

• Platform safeguards include clinician review, physician oversight of AI recommendations, SOC 2 Type 1 and HIPAA-oriented privacy and security controls.